MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NAGE — Niagen Bioscience, Inc. Common Stock
NasdaqNiagen Bioscience, Inc. Common Stock
$2.69
+0.01(+0.37%)
- O
- 2.67
- H
- 2.71
- L
- 2.66
- V
- 368.31K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About NAGE
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
SectorNot available
IPO DateJun 24, 2008
Employees117
Stock ExchangeNasdaq
Ticker SymbolNAGE
Key Financial Statistics
| Market Cap | $220.76M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.61 - $7.95 |
| 52-Week Avg Volume | 887.6K |
| VWAP | $2.69 |
| Transactions | 3,783 |
| Total Recorded Bars | 4,598 days |